DJIA 16,919.59 80.85 0.48%
NASDAQ 4,527.51 19.20 0.43%
S&P 500 1,981.60 9.86 0.50%
market minute promo

Biogen Idec (NASDAQ: BIIB)



company name or ticker
Company Photos
(Click to zoom)

Celgene Beats Q2 Earnings Estimates on Strong Revlimid Sales - Analyst Blog

AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus - Analyst Blog

AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus - Analyst Blog

UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog

Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog

Why Biogen Idec Stock Is Firing on All Cylinders

Biogen Idec's latest earnings report is the envy of the industry with better than expected growth of its soon to be best-seller Tecfidera.

IYH, PFE, ABBV, BIIB: Large Outflows Detected at ETF

Cramer: Every Which Way But Short

U.S. stocks: Futures up as Ford, Facebook rise premarket

Jim Cramer's Top Stock Picks: PEP CELG GILD REGN BIIB CMG

Avanir to Conduct Phase II Study on AVP-786 for Depression - Analyst Blog

See More Articles...